Abiopharma

📋 Che Austin (Officer) plans to sell 2K shares of Ginkgo Bioworks Holdings, Inc. (at $9.16 each, total $20K) Filed: Jan 07, 2026 | ID: 000178

BioHarvest Sciences Issues Year End Shareholder Letter

(10% Negative) Enliven Therapeutics, Inc. (IMRA) Announces Delay in trial Development Timeline Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(68% Positive) Sera Prognostics, Inc. (SERA) Announces Enrollment Update for birth Due to Pandemic-Related Challenges, Patient Enrollment Issues, Efficacy Assessment

Study showed MiniMed™ 780G system achieved ADA-recommended time-in-range goals even on days users forgot to bolus

Oncolytics Biotech Inc (ONCY) Files Form 6-K

DexCom, Inc. - Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer

Tenet - Tenet to Report its Fourth Quarter 2025 Results on February 11th

Masimo - Masimo to Present in the J.P. Morgan 2026 Healthcare Conference

Codexis Expands Reach of the ECO Synthesis®Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics

(99% Neutral) Cidara Therapeutics, Inc. (CDTX) Announces Business Combination

Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer

Rapid Micro Biosystems to Present at 44th Annual J.P. Morgan Healthcare Conference

New Form SC 14D9/A - Cidara Therapeutics, Inc. Filed: 2026-01-07 AccNo: 0001193125-26-005515 Size: 17 KB

(30% Negative) ORAMED PHARMACEUTICALS INC. (ORMP) Announces Delay in scheduled Trials for Scilex products Due to Regulatory Process